Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 29 Jun 2026 for Acadia Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleJames Kihara
Insider track record
Disclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James Kihara: trading record in brief
All filings by James Kihara on record concern Acadia Pharmaceuticals Inc, in the capacity of senior executive. Between 23 February 2022 and 26 June 2026, the trades on record add up to 38 filings.
Sales make up the whole of the open-market record (16 sales, €509k). The amount is not disclosed for 1 filing. Besides market trades, the filings include 22 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The latest filing, published on 29 June 2026, reports an open-market sale in Acadia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James Kihara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
11,421 sharesCommon StockSEC:0001816160-26-000009:0
5,401 shares@ US$21.180.0022% mcap19.3% of flowCommon StockSEC:0001816160-26-000008:0
1,332 shares@ US$21.790.0005% mcap4.9% of flowCommon StockSEC:0001816160-26-000007:1
2,596 sharesCommon StockSEC:0001816160-26-000007:0
1,030 shares@ US$22.200.0004% mcap3.8% of flowCommon StockSEC:0001816160-26-000005:1
2,010 sharesCommon StockSEC:0001816160-26-000005:0
1,627 sharesCommon StockSEC:0001816160-26-000003:0
3,966 sharesCommon StockSEC:0001816160-25-000004:0
2,000 shares@ US$25.008.8% of flowCommon StockSEC:0001415889-25-013742:0
2,596 sharesCommon StockSEC:0001415889-25-011875:0
1,028 shares@ US$14.822.7% of flowCommon StockSEC:0001415889-25-010423:1
2,010 sharesCommon StockSEC:0001415889-25-010423:0
2,142 sharesCommon StockSEC:0001415889-25-009075:0
475 shares@ US$19.961.8% of flowCommon StockSEC:0001415889-25-005575:1
840 sharesCommon StockSEC:0001415889-25-005575:0
4,073 shares@ US$16.8112.7% of flowCommon StockSEC:0001415889-24-027293:2
3,965 sharesCommon StockSEC:0001415889-24-027293:0
3,965 sharesCommon StockSEC:0001415889-24-027293:1
2,596 sharesCommon StockSEC:0001415889-24-012236:0
1,028 shares@ US$17.873.3% of flowCommon StockSEC:0001415889-24-010602:2
762 shares@ US$17.872.5% of flowCommon StockSEC:0001415889-24-010602:3
2,010 sharesCommon StockSEC:0001415889-24-010602:0
1,489 sharesCommon StockSEC:0001415889-24-010602:1
840 sharesCommon StockSEC:0001415889-24-005574:0
474 shares@ US$24.672.1% of flowCommon StockSEC:0001415889-24-005574:1
25 of 38 declarations
